Publications in collaboration with researchers from Universitat Jaume I (23)

2024

  1. Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity

    Obesity Research and Clinical Practice

  2. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

  3. β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction

    JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396

2023

  1. Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 511-518

  2. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

    Scientific Reports, Vol. 13, Núm. 1

  3. Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792

2022

  1. Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826

2021

  1. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure

    European Journal of Internal Medicine, Vol. 92, pp. 94-99

  2. Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction

    Journal of the American College of Cardiology, Vol. 78, Núm. 21, pp. 2042-2056

  3. Matrix metalloproteinase-12 cleaved fragment of titin as a predictor of functional capacity in patients with heart failure and preserved ejection fraction

    Scandinavian Cardiovascular Journal, Vol. 55, Núm. 1, pp. 9-14

2020

  1. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  2. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 463-470

  3. Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial

    Journal of the American Heart Association, Vol. 9, Núm. 4

  4. Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction

    ESC Heart Failure, Vol. 7, Núm. 3, pp. 1007-1014

  5. Right ventricular dysfunction staging system for mortality risk stratification in heart failure with preserved ejection fraction

    Journal of Clinical Medicine, Vol. 9, Núm. 3

2019

  1. Usefulness of Right Ventricular to Pulmonary Circulation Coupling as an Indicator of Risk for Recurrent Admissions in Heart Failure With Preserved Ejection Fraction

    American Journal of Cardiology, Vol. 124, Núm. 4, pp. 567-572

2018

  1. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design

    Clinical Cardiology, Vol. 41, Núm. 6, pp. 729-735

2017

  1. Carga de hospitalizaciones recurrentes tras una hospitalización por insuficiencia cardiaca aguda: insuficiencia cardiaca con función sistólica conservada frente a reducida

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 239-246

2016

  1. Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial

    Clinical Cardiology, Vol. 39, Núm. 8, pp. 433-439

  2. Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction

    International Journal of Cardiology, Vol. 207, pp. 365-367